These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

243 related articles for article (PubMed ID: 16715124)

  • 1. Ras transformation requires metabolic control by 6-phosphofructo-2-kinase.
    Telang S; Yalcin A; Clem AL; Bucala R; Lane AN; Eaton JW; Chesney J
    Oncogene; 2006 Nov; 25(55):7225-34. PubMed ID: 16715124
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Regulation of glucose metabolism by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatases in cancer.
    Yalcin A; Telang S; Clem B; Chesney J
    Exp Mol Pathol; 2009 Jun; 86(3):174-9. PubMed ID: 19454274
    [TBL] [Abstract][Full Text] [Related]  

  • 3. 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase and tumor cell glycolysis.
    Chesney J
    Curr Opin Clin Nutr Metab Care; 2006 Sep; 9(5):535-9. PubMed ID: 16912547
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Phosphorylation of the 6-phosphofructo-2-kinase/fructose 2,6-bisphosphatase/PFKFB3 family of glycolytic regulators in human cancer.
    Bando H; Atsumi T; Nishio T; Niwa H; Mishima S; Shimizu C; Yoshioka N; Bucala R; Koike T
    Clin Cancer Res; 2005 Aug; 11(16):5784-92. PubMed ID: 16115917
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Small-molecule inhibition of 6-phosphofructo-2-kinase activity suppresses glycolytic flux and tumor growth.
    Clem B; Telang S; Clem A; Yalcin A; Meier J; Simmons A; Rasku MA; Arumugam S; Dean WL; Eaton J; Lane A; Trent JO; Chesney J
    Mol Cancer Ther; 2008 Jan; 7(1):110-20. PubMed ID: 18202014
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Small molecule inhibition of 6-phosphofructo-2-kinase suppresses t cell activation.
    Telang S; Clem BF; Klarer AC; Clem AL; Trent JO; Bucala R; Chesney J
    J Transl Med; 2012 May; 10():95. PubMed ID: 22591674
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Fructose-2,6-bisphosphate synthesis by 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase 4 (PFKFB4) is required for the glycolytic response to hypoxia and tumor growth.
    Chesney J; Clark J; Klarer AC; Imbert-Fernandez Y; Lane AN; Telang S
    Oncotarget; 2014 Aug; 5(16):6670-86. PubMed ID: 25115398
    [TBL] [Abstract][Full Text] [Related]  

  • 8. High expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase (iPFK-2; PFKFB3) in human cancers.
    Atsumi T; Chesney J; Metz C; Leng L; Donnelly S; Makita Z; Mitchell R; Bucala R
    Cancer Res; 2002 Oct; 62(20):5881-7. PubMed ID: 12384552
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Expression of inducible 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase/PFKFB3 isoforms in adipocytes and their potential role in glycolytic regulation.
    Atsumi T; Nishio T; Niwa H; Takeuchi J; Bando H; Shimizu C; Yoshioka N; Bucala R; Koike T
    Diabetes; 2005 Dec; 54(12):3349-57. PubMed ID: 16306349
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Glucose-induced stimulation of the Ras-cAMP pathway in yeast leads to multiple phosphorylations and activation of 6-phosphofructo-2-kinase.
    Dihazi H; Kessler R; Eschrich K
    Biochemistry; 2003 May; 42(20):6275-82. PubMed ID: 12755632
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Cloning and chromosomal characterization of the 6-phosphofructo-2-kinase/fructose-2,6-bisphosphatase-3 gene (PFKFB3, iPFK2).
    Mahlknecht U; Chesney J; Hoelzer D; Bucala R
    Int J Oncol; 2003 Oct; 23(4):883-91. PubMed ID: 12963966
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Nitric oxide switches on glycolysis through the AMP protein kinase and 6-phosphofructo-2-kinase pathway.
    Almeida A; Moncada S; Bolaños JP
    Nat Cell Biol; 2004 Jan; 6(1):45-51. PubMed ID: 14688792
    [TBL] [Abstract][Full Text] [Related]  

  • 13. 6-Phosphofructo-2-kinase (PFKFB3) promotes cell cycle progression and suppresses apoptosis via Cdk1-mediated phosphorylation of p27.
    Yalcin A; Clem BF; Imbert-Fernandez Y; Ozcan SC; Peker S; O'Neal J; Klarer AC; Clem AL; Telang S; Chesney J
    Cell Death Dis; 2014 Jul; 5(7):e1337. PubMed ID: 25032860
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The PFKFB3 splice variant UBI2K4 is downregulated in high-grade astrocytomas and impedes the growth of U87 glioblastoma cells.
    Zscharnack K; Kessler R; Bleichert F; Warnke JP; Eschrich K
    Neuropathol Appl Neurobiol; 2009 Dec; 35(6):566-78. PubMed ID: 19490427
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Inhibition of 6-phosphofructo-2-kinase (PFKFB3) suppresses glucose metabolism and the growth of HER2+ breast cancer.
    O'Neal J; Clem A; Reynolds L; Dougherty S; Imbert-Fernandez Y; Telang S; Chesney J; Clem BF
    Breast Cancer Res Treat; 2016 Nov; 160(1):29-40. PubMed ID: 27613609
    [TBL] [Abstract][Full Text] [Related]  

  • 16. PFKFB3 gene silencing decreases glycolysis, induces cell-cycle delay and inhibits anchorage-independent growth in HeLa cells.
    Calvo MN; Bartrons R; Castaño E; Perales JC; Navarro-Sabaté A; Manzano A
    FEBS Lett; 2006 May; 580(13):3308-14. PubMed ID: 16698023
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Targeted disruption of inducible 6-phosphofructo-2-kinase results in embryonic lethality.
    Chesney J; Telang S; Yalcin A; Clem A; Wallis N; Bucala R
    Biochem Biophys Res Commun; 2005 May; 331(1):139-46. PubMed ID: 15845370
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Expression of PFKFB3 and Ki67 in lung adenocarcinomas and targeting PFKFB3 as a therapeutic strategy.
    Li X; Liu J; Qian L; Ke H; Yao C; Tian W; Liu Y; Zhang J
    Mol Cell Biochem; 2018 Aug; 445(1-2):123-134. PubMed ID: 29327288
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Pfkfb3 is transcriptionally upregulated in diabetic mouse liver through proliferative signals.
    Duran J; Obach M; Navarro-Sabate A; Manzano A; Gómez M; Rosa JL; Ventura F; Perales JC; Bartrons R
    FEBS J; 2009 Aug; 276(16):4555-68. PubMed ID: 19645723
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Fructose-2,6-bisphosphate counteracts guanidinium chloride-, thermal-, and ATP-induced dissociation of skeletal muscle key glycolytic enzyme 6-phosphofructo-1-kinase: A structural mechanism for PFK allosteric regulation.
    Zancan P; Almeida FV; Faber-Barata J; Dellias JM; Sola-Penna M
    Arch Biochem Biophys; 2007 Nov; 467(2):275-82. PubMed ID: 17923106
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.